Poly Medicure Limited

NSEI:POLYMED Stock Report

Market Cap: ₹190.0b

Poly Medicure Management

Management criteria checks 2/4

Poly Medicure's CEO is Himanshu Baid, appointed in Sep 1995, has a tenure of 28.75 years. total yearly compensation is ₹130.06M, comprised of 42.3% salary and 57.7% bonuses, including company stock and options. directly owns 12.24% of the company’s shares, worth ₹23.25B. The average tenure of the management team and the board of directors is 6 years and 11 years respectively.

Key information

Himanshu Baid

Chief executive officer

₹130.1m

Total compensation

CEO salary percentage42.3%
CEO tenure28.8yrs
CEO ownership12.2%
Management average tenure6yrs
Board average tenure11yrs

Recent management updates

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Recent updates

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

Mar 01
Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Feb 01
How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Jan 17
Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 09
Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Nov 24
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Nov 09
Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Oct 26
Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Oct 06
Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Sep 17
Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Sep 02
Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

CEO Compensation Analysis

How has Himanshu Baid's remuneration changed compared to Poly Medicure's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₹3b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹130m₹55m

₹2b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹1b

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹107m₹49m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹92m₹44m

₹1b

Dec 31 2020n/an/a

₹1b

Sep 30 2020n/an/a

₹1b

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹62m₹35m

₹959m

Dec 31 2019n/an/a

₹947m

Sep 30 2019n/an/a

₹858m

Jun 30 2019n/an/a

₹719m

Mar 31 2019₹44m₹14m

₹654m

Mar 31 2018₹41m₹14m

₹706m

Compensation vs Market: Himanshu's total compensation ($USD1.56M) is above average for companies of similar size in the Indian market ($USD444.28K).

Compensation vs Earnings: Himanshu's compensation has increased by more than 20% in the past year.

CEO

Himanshu Baid (56 yo)

28.8yrs

Tenure

₹130,063,000

Compensation

Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...

Leadership Team

NamePositionTenureCompensationOwnership
Himanshu Baid
CEO, MD & Director28.8yrs₹130.06m12.24%
₹ 23.3b
Jugal Baid
Founder & Non Executive Directorno data₹1.43m2.38%
₹ 4.5b
Naresh Vijayvergiya
Chief Financial Officer2.9yrs₹9.90mno data
Avinash Chandra
Company Secretary & Compliance Officer9.1yrs₹1.67mno data
Rishi Baid
Joint MD & Executive Directorno data₹124.73m13.07%
₹ 24.8b
Vishal Baid
President of Corporate Sales & Marketing2.2yrs₹17.15m1.75%
₹ 3.3b
P. Rastogi
Assistant Vice President of Finance & Accountsno datano datano data
Hemant Bhalla
Senior Vice President of Domestic Sales & Marketingno data₹5.79mno data
Pankaj Gupta
President of R&Dno data₹5.61mno data
Manish Sardana
President of Sales & Marketing - Indiano data₹8.61mno data

6.0yrs

Average Tenure

56yo

Average Age

Experienced Management: POLYMED's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Himanshu Baid
CEO, MD & Director29.3yrs₹130.06m12.24%
₹ 23.3b
Jugal Baid
Founder & Non Executive Director29.3yrs₹1.43m2.38%
₹ 4.5b
Rishi Baid
Joint MD & Executive Director29.3yrs₹124.73m13.07%
₹ 24.8b
Amit Khosla
Non-Executive Independent Director4yrs₹1.58mno data
Devendra Mehta
Non-Executive Independent Chairman19.1yrs₹1.60mno data
Prakash Surana
Non-Executive Independent Director26.8yrs₹1.40m0.0011%
₹ 2.2m
Mukulika Baid
Non-Executive Director9.9yrs₹1.43m3.19%
₹ 6.1b
Shailendra Mehta
Non-Executive Independent Director12.1yrs₹1.55mno data
Sonal Mattoo
Non-Executive Independent Director3.8yrs₹1.48m0.000040%
₹ 76.0k
Sandeep Bhargava
Non-Executive Independent Director7.3yrs₹1.45mno data
Alessandro Balboni
Non-Executive Non Independent Director6.1yrsno datano data
Ambrish Mithal
Independent Director2.2yrs₹900.00kno data

11.0yrs

Average Tenure

64yo

Average Age

Experienced Board: POLYMED's board of directors are seasoned and experienced ( 11 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.